首页> 外文期刊>Cancer Biomarkers >Quantitative diffusion weighted MRI: A functional biomarker of nodal disease in Hodgkin lymphoma?
【24h】

Quantitative diffusion weighted MRI: A functional biomarker of nodal disease in Hodgkin lymphoma?

机译:定量弥散加权MRI:霍奇金淋巴瘤淋巴结转移的功能性生物标志?

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: This study explores the relationship between MRI Apparent Diffusion Coefficient (ADC) and PET Standardized Uptake Value (SUV) measurements in pediatric Hodgkin lymphoma. Methods: Sixteen patients (mean age 15.4 yrs, 8 male) with proven Hodgkin lymphoma were recruited and staged using PET-CT, anatomical MRI and additional 1.5T diffusion weighted imaging (DWI) prior to and following chemotherapy. Pre-treatment lymph nodes and anatomically paired post-treatment residual tissue located on MRI were matched to the corresponding PET-CT. Region of interest (ROI) analysis was used to extract quantitative measurements. Mean ADC (ADC_{mean}) and maximum SUV (SUV_{max}) were recorded and correlation assessed using Spearman statistics. Results: Fifty-three ROIs were sampled. Pre- and post-treatment ADC_{mean} ranged from 0.77 × 10^{-3} to 1.79 × 10^{-3} (median 1.15 × 10^{-3} mm^{2}s^{-1}) and 1.08 × 10^{-3} to 3.18 × 10^{-3} (median 1.88 × 10^{-3}mm^{2}s^{-1}), and SUV_{max} from 2.60 to 25.4 (median 8.85 mg/ml) and 1.00 to 3.50 mg/ml (median 1.90 mg/ml). Median post-treatment ADC_{mean} was higher, and median SUV_{max} lower than pre-treatment values (p< 0.0001). There was an inverse correlation between pre-treatment ADC_{mean} and SUV_{max} (p=0.005) and between fractional change ([post-treatment – pre-treatment]/pre-treatment) in ADC_{mean} and SUV_{max} (p=0.002). Conclusion: Our results confirm a strong~reciprocal relationship between nodal ADC_{mean} and SUV_{max} in Hodgkin lymphoma; supporting the potential application of quantitative DWI as a functional biomarker of disease.
机译:目的:本研究探讨小儿霍奇金淋巴瘤的MRI表观扩散系数(ADC)与PET标准化摄取值(SUV)测量之间的关系。方法:在化疗前后,采用PET-CT,解剖MRI和附加的1.5T弥散加权成像(DWI)招募16例确诊霍奇金淋巴瘤的患者(平均年龄15.4岁,男8例),并分期进行。将位于MRI上的治疗前淋巴结和解剖学上配对的治疗后残留组织与相应的PET-CT相匹配。感兴趣区域(ROI)分析用于提取定量测量。记录平均ADC(ADC_ {mean})和最大SUV(SUV_ {max}),并使用Spearman统计量评估相关性。结果:抽取了53个ROI。治疗前后的ADC_ {mean}为0.77×10 ^ {-3}至1.79×10 ^ {-3}(中位数为1.15×10 ^ {-3} mm ^ {2} s ^ {-1} )和1.08×10 ^ {-3}至3.18×10 ^ {-3}(中位数1.88×10 ^ {-3} mm ^ {2} s ^ {-1})和SUV_ {max}从2.60至25.4(中位数8.85 mg / ml)和1.00至3.50 mg / ml(中位数1.90 mg / ml)。治疗后的中位数ADC_ {mean}高于治疗前的中位数SUV_ {max}(p <0.0001)。预处理ADC_ {mean}和SUV_ {max}之间(p = 0.005)与ADC_ {mean}和SUV_ {中的分数变化([后处理–预处理] /预处理)之间存在负相关。 max}(p = 0.002)。结论:我们的结果证实了霍奇金淋巴瘤的结节ADC_ {mean}和SUV_ {max}之间存在很强的相互关系。支持定量DWI作为疾病功能性生物标志物的潜在应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号